These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 9514541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ, Prigeon RL, D'Alessio DA.
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D.
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T, Toft-Nielsen MB, Krarup T, Madsbad S, Dinesen B, Holst JJ.
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [Abstract] [Full Text] [Related]

  • 6. Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients.
    Johnston C, Ward WK, Beard JC, McKnight B, Porte D.
    Diabet Med; 1990 Feb; 7(2):119-25. PubMed ID: 2137751
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP, Knudsen SH, Karstoft K, Winding K, Holst JJ, Pedersen BK.
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [Abstract] [Full Text] [Related]

  • 9. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
    Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M.
    Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901
    [Abstract] [Full Text] [Related]

  • 10. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B, Larsson H, Holst JJ.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [Abstract] [Full Text] [Related]

  • 11. Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM.
    Van Haeften TW, Van Maarschalkerweerd WW, Gerich JE, Van der Veen EA.
    Eur J Clin Invest; 1991 Apr; 21(2):168-74. PubMed ID: 1905629
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB.
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [Abstract] [Full Text] [Related]

  • 14. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
    Asplin CM, Paquette TL, Palmer JP.
    J Clin Invest; 1981 Jul; 68(1):314-8. PubMed ID: 7019246
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.
    Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation.
    Christiansen E, Tibell A, Vølund A, Rasmussen K, Groth CG, Holst JJ, Pedersen O, Christensen NJ, Madsbad S.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3972-9. PubMed ID: 8923846
    [Abstract] [Full Text] [Related]

  • 17. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
    Grill V, Efendić S.
    Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A, Stefan N, Hardt E, Häring H, Stumvoll M.
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [Abstract] [Full Text] [Related]

  • 20. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.
    Gjessing HJ, Reinholdt B, Pedersen O.
    Diabetologia; 1989 Dec; 32(12):858-63. PubMed ID: 2693165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.